Data / Form D filings / Alphageneron Pharmaceuticals, Inc.
Alphageneron Pharmaceuticals, Inc.: Form D filing
Alphageneron Pharmaceuticals, Inc., a pharmaceuticals company in New York, NY, filed a Form D with the SEC in 2023. The latest, on August 14, 2023, reports $250,000 sold of a $250,000 offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1441 BROADWAY, 3RD FLOOR, STE #3159, New York, NY, 10018
- Phone
- (646) 569-5522
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1812191
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 14, 2023 | New notice | $250,000 | $250,000 | 1 | Jun 20, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert Brooks | Executive Officer, Director | |
| Ola Soderquist | Executive Officer | |
| Marc Lippman | Director | |
| Bikash Verma | Director | |
| Robert Clarke | Director | |
| Graham Pockley | Executive Officer |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Aug 14, 2023 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Alphageneron Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.